• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亲水残基对于核糖体蛋白 L11(RPL11)与 MDM2 的锌指结构域和 p53 蛋白的相互作用以及 p53 蛋白的激活至关重要。

Hydrophilic residues are crucial for ribosomal protein L11 (RPL11) interaction with zinc finger domain of MDM2 and p53 protein activation.

机构信息

Department of Biochemistry and Molecular Biology, Indiana University School of Medicine-Simon Cancer Center, Indianapolis, Indiana 46032.

Department of Pathology, Albert Einstein College of Medicine of Yeshiva University, Bronx, New York 10461.

出版信息

J Biol Chem. 2011 Nov 4;286(44):38264-38274. doi: 10.1074/jbc.M111.277012. Epub 2011 Sep 8.

DOI:10.1074/jbc.M111.277012
PMID:21903592
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3207392/
Abstract

Ribosomal protein L11 (RPL11) has been shown to activate p53 by binding to MDM2 and negating its p53 suppression activity in response to ribosomal stress. Although a mutation at Cys-305 within the zinc finger domain of MDM2 has been shown to drastically impair MDM2 interaction with RPL11 and thus escapes the inhibition by this ribosomal protein, it still remains elusive whether RPL11 inactivates MDM2 via direct action on this zinc finger domain and what is the chemical nature of this specific interaction. To define the roles of the MDM2 zinc finger in association with RPL11, we conducted hydrogen-deuterium exchange mass spectrometry, computational modeling, circular dichroism, and mutational analyses of the zinc finger domain of MDM2 and human RPL11. Our study reveals that RPL11 forms a stable complex with MDM2 in vitro through direct contact with its zinc finger. This binding is disrupted by single mutations of non-cysteine amino acids within the zinc finger domain of MDM2. Basic residues in RPL11 are crucial for the stable binding and RPL11 suppression of MDM2 activity toward p53. These results provide the first line of evidence for the specific interaction between RPL11 and the zinc finger of MDM2 via hydrophilic residues as well as a molecular foundation for better understanding RPL11 inhibition of MDM2 function.

摘要

核糖体蛋白 L11(RPL11)已被证明通过与 MDM2 结合并消除其对核糖体应激的 p53 抑制活性来激活 p53。虽然已经表明 MDM2 锌指结构域内的 Cys-305 突变会严重损害 MDM2 与 RPL11 的相互作用,从而逃避这种核糖体蛋白的抑制,但仍然不清楚 RPL11 是否通过直接作用于该锌指结构域使 MDM2 失活,以及这种特定相互作用的化学性质是什么。为了确定 MDM2 锌指在与 RPL11 相关联中的作用,我们进行了氢氘交换质谱、计算建模、圆二色性和 MDM2 及人 RPL11 锌指结构域的突变分析。我们的研究表明,RPL11 通过与锌指直接接触,在体外与 MDM2 形成稳定的复合物。这种结合会被锌指结构域中 MDM2 的非半胱氨酸氨基酸的单个突变所破坏。RPL11 中的碱性残基对于稳定结合和 RPL11 抑制 MDM2 对 p53 的活性至关重要。这些结果为 RPL11 与 MDM2 的锌指之间通过亲水性残基的特异性相互作用提供了第一手证据,也为更好地理解 RPL11 抑制 MDM2 功能提供了分子基础。

相似文献

1
Hydrophilic residues are crucial for ribosomal protein L11 (RPL11) interaction with zinc finger domain of MDM2 and p53 protein activation.亲水残基对于核糖体蛋白 L11(RPL11)与 MDM2 的锌指结构域和 p53 蛋白的相互作用以及 p53 蛋白的激活至关重要。
J Biol Chem. 2011 Nov 4;286(44):38264-38274. doi: 10.1074/jbc.M111.277012. Epub 2011 Sep 8.
2
Structure of human MDM2 complexed with RPL11 reveals the molecular basis of p53 activation.与RPL11复合的人MDM2结构揭示了p53激活的分子基础。
Genes Dev. 2015 Jul 15;29(14):1524-34. doi: 10.1101/gad.261792.115.
3
Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation.MDM2锌指结构域中的癌症相关突变会破坏核糖体蛋白相互作用,并减弱MDM2诱导的p53降解。
Mol Cell Biol. 2007 Feb;27(3):1056-68. doi: 10.1128/MCB.01307-06. Epub 2006 Nov 20.
4
Putting a finger on growth surveillance: insight into MDM2 zinc finger-ribosomal protein interactions.聚焦生长监测:深入了解MDM2锌指蛋白与核糖体蛋白的相互作用
Cell Cycle. 2007 Feb 15;6(4):434-7. doi: 10.4161/cc.6.4.3861. Epub 2007 Feb 18.
5
An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction.一个由核糖体蛋白-Mdm2 相互作用介导的 ARF 非依赖性 c-MYC 激活的肿瘤抑制途径。
Cancer Cell. 2010 Sep 14;18(3):231-43. doi: 10.1016/j.ccr.2010.08.007.
6
GRWD1 negatively regulates p53 via the RPL11-MDM2 pathway and promotes tumorigenesis.GRWD1通过RPL11-MDM2途径负向调节p53并促进肿瘤发生。
EMBO Rep. 2017 Jan;18(1):123-137. doi: 10.15252/embr.201642444. Epub 2016 Nov 17.
7
Identification of a small-molecule RPL11 mimetic that inhibits tumor growth by targeting MDM2-p53 pathway.鉴定一种小分子 RPL11 模拟物,通过靶向 MDM2-p53 通路抑制肿瘤生长。
Mol Med. 2022 Sep 7;28(1):109. doi: 10.1186/s10020-022-00537-x.
8
The RP-Mdm2-p53 pathway and tumorigenesis.核糖体蛋白-小鼠双微体2-抑癌基因p53信号通路与肿瘤发生
Oncotarget. 2011 Mar;2(3):234-8. doi: 10.18632/oncotarget.228.
9
Recruitment of RPL11 at promoter sites of p53-regulated genes upon nucleolar stress through NEDD8 and in an Mdm2-dependent manner.核仁应激时通过 NEDD8 并依赖于 Mdm2 将 RPL11 募集到 p53 调控基因的启动子位点。
Oncogene. 2012 Jun 21;31(25):3060-71. doi: 10.1038/onc.2011.482. Epub 2011 Nov 14.
10
Ribosomal protein RPL11 haploinsufficiency causes anemia in mice via activation of the RP-MDM2-p53 pathway.核糖体蛋白 RPL11 杂合不足通过激活 RP-MDM2-p53 通路导致小鼠贫血。
J Biol Chem. 2023 Jan;299(1):102739. doi: 10.1016/j.jbc.2022.102739. Epub 2022 Nov 23.

引用本文的文献

1
Single-Cell Sequence and Machine Learning Identify a CD79A+B Cells-Related Transcriptional Signature for Predicting Clinical Outcomes and Immune Microenvironment in Breast Cancer.单细胞测序与机器学习识别出一种与CD79A+B细胞相关的转录特征,用于预测乳腺癌的临床结局和免疫微环境。
Cancer Inform. 2025 Jul 26;24:11769351251360675. doi: 10.1177/11769351251360675. eCollection 2025.
2
Structure and function of MDM2 and MDM4 in health and disease.MDM2和MDM4在健康与疾病中的结构与功能
Biochem J. 2025 Feb 17;482(4):BCJ20240757. doi: 10.1042/BCJ20240757.
3
Silencing Ribosomal Protein L22 Promotes Proliferation and Migration, and Inhibits Apoptosis of Gastric Cancer Cells by Regulating the Murine Double Minute 2-Protein 53 (MDM2-p53) Signaling Pathway.沉默核糖体蛋白 L22 通过调节鼠双微体 2 蛋白 53(MDM2-p53)信号通路促进胃癌细胞的增殖和迁移,抑制其凋亡。
Med Sci Monit. 2021 May 29;27:e928375. doi: 10.12659/MSM.928375.
4
BOP1 Knockdown Attenuates Neointimal Hyperplasia by Activating p53 and Inhibiting Nascent Protein Synthesis.BOP1 敲低通过激活 p53 和抑制新生蛋白质合成来减轻内膜增生。
Oxid Med Cell Longev. 2021 Jan 16;2021:5986260. doi: 10.1155/2021/5986260. eCollection 2021.
5
RBM10, a New Regulator of p53.RBM10,一种新的 p53 调节剂。
Cells. 2020 Sep 16;9(9):2107. doi: 10.3390/cells9092107.
6
Regulation by Cyclic GMP-AMP Synthase/Interferon Regulatory Factor 3 and Modulation of Expression via .环状鸟苷酸-腺苷酸合酶/干扰素调节因子 3 的调节及通过. 的表达调控
Mol Cell Biol. 2020 Mar 30;40(8). doi: 10.1128/MCB.00471-19.
7
An improved method for the heterologous production of soluble human ribosomal proteins in Escherichia coli.一种提高大肠杆菌中可溶性人核糖体蛋白异源表达的方法。
Sci Rep. 2019 Jun 20;9(1):8884. doi: 10.1038/s41598-019-45323-8.
8
A single synonymous mutation determines the phosphorylation and stability of the nascent protein.单一同义突变决定了新生蛋白的磷酸化和稳定性。
J Mol Cell Biol. 2019 Mar 1;11(3):187-199. doi: 10.1093/jmcb/mjy049.
9
Cancer-mutated ribosome protein L22 (RPL22/eL22) suppresses cancer cell survival by blocking p53-MDM2 circuit.癌症突变的核糖体蛋白L22(RPL22/eL22)通过阻断p53-MDM2回路来抑制癌细胞存活。
Oncotarget. 2017 Oct 6;8(53):90651-90661. doi: 10.18632/oncotarget.21544. eCollection 2017 Oct 31.
10
Mdm2 mediates FMRP- and Gp1 mGluR-dependent protein translation and neural network activity.Mdm2介导FMRP和Gp1代谢型谷氨酸受体依赖性蛋白质翻译及神经网络活动。
Hum Mol Genet. 2017 Oct 15;26(20):3895-3908. doi: 10.1093/hmg/ddx276.

本文引用的文献

1
Diamond Blackfan anemia and ribosome biogenesis: introduction.先天性纯红细胞再生障碍性贫血与核糖体生物发生:引言
Semin Hematol. 2011 Apr;48(2):73-4. doi: 10.1053/j.seminhematol.2011.01.003.
2
Crystal structure of the eukaryotic ribosome.真核生物核糖体的晶体结构。
Science. 2010 Nov 26;330(6008):1203-9. doi: 10.1126/science.1194294.
3
PAK1IP1, a ribosomal stress-induced nucleolar protein, regulates cell proliferation via the p53-MDM2 loop.PAK1IP1,一种核糖体应激诱导的核仁蛋白,通过 p53-MDM2 循环调节细胞增殖。
Nucleic Acids Res. 2011 Mar;39(6):2234-48. doi: 10.1093/nar/gkq1117. Epub 2010 Nov 21.
4
The nucleolus under stress.应激状态下的核仁
Mol Cell. 2010 Oct 22;40(2):216-27. doi: 10.1016/j.molcel.2010.09.024.
5
Depletion of ribosomal protein L37 occurs in response to DNA damage and activates p53 through the L11/MDM2 pathway.核糖体蛋白 L37 的耗竭是对 DNA 损伤的响应,并通过 L11/MDM2 通路激活 p53。
Cell Cycle. 2010 Oct 1;9(19):4005-12. doi: 10.4161/cc.9.19.13299. Epub 2010 Oct 9.
6
An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction.一个由核糖体蛋白-Mdm2 相互作用介导的 ARF 非依赖性 c-MYC 激活的肿瘤抑制途径。
Cancer Cell. 2010 Sep 14;18(3):231-43. doi: 10.1016/j.ccr.2010.08.007.
7
Achieving reliability and high accuracy in automated protein docking: ClusPro, PIPER, SDU, and stability analysis in CAPRI rounds 13-19.在自动化蛋白质对接中实现可靠性和高精度:ClusPro、PIPER、SDU 以及 CAPRI 第 13-19 轮的稳定性分析。
Proteins. 2010 Nov 15;78(15):3124-30. doi: 10.1002/prot.22835.
8
A transgenic mouse model demonstrates a dominant negative effect of a point mutation in the RPS19 gene associated with Diamond-Blackfan anemia.一个转基因小鼠模型显示 RPS19 基因突变与 Diamond-Blackfan 贫血相关的显性负效应。
Blood. 2010 Oct 14;116(15):2826-35. doi: 10.1182/blood-2010-03-275776. Epub 2010 Jul 6.
9
Perturbation of 60 S ribosomal biogenesis results in ribosomal protein L5- and L11-dependent p53 activation.60S 核糖体生物发生的扰动导致核糖体蛋白 L5 和 L11 依赖性 p53 的激活。
J Biol Chem. 2010 Aug 13;285(33):25812-21. doi: 10.1074/jbc.M109.098442. Epub 2010 Jun 16.
10
Negative regulation of HDM2 to attenuate p53 degradation by ribosomal protein L26.负向调控 HDM2,抑制核糖体蛋白 L26 介导的 p53 降解。
Nucleic Acids Res. 2010 Oct;38(19):6544-54. doi: 10.1093/nar/gkq536. Epub 2010 Jun 11.